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This longitudinal study aimed to document (i) the information-giving and patient-communication styles of clinical geneticists and
genetic counsellors (consultants) in familial breast cancer clinics and (ii) assess the effect of these styles on women’s knowledge,
whether their expectations were met, satisfaction, risk perception and psychological status. A total of 158 women from high-risk
breast cancer families completed self-report questionnaires at 2 weeks preconsultation and 4 weeks postconsultation. The
consultations were audiotaped, transcribed and coded. Multivariate logistic regressions showed that discussing prophylactic
mastectomy (P¼0.00) and oophorectomy (P¼0.01) led to women having significantly more expectations met; discussing genetic
testing significantly decreased anxiety (P¼0.03) and facilitating understanding significantly decreased depression (P¼0.05). Receiving
a summary letter of the consultation significantly lowered anxiety (P¼0.01) and significantly increased the accuracy of perceived risk
(P¼0.02). Women whose consultant used more supportive communications experienced significantly more anxiety about breast
cancer at the 4 weeks follow-up (P¼0.00). These women were not significantly more anxious before genetic counselling. In
conclusion, this study found that consultants vary in the amount of information they give and the way they communicate; and this
variation can result in better or worse psychosocial outcomes. Greater use of supportive and counselling communications appeared
to increase anxiety about breast cancer. Identifying methods to assist consultants to address emotional issues effectively may be
helpful.
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Women who are concerned about their cancer risk because of their
family history should have access to accurate information and
referral for cancer genetic counselling (including risk estimation).
While many studies have explored women’s expectations of the
session, their risk perceptions, their psychological state and their
testing and screening intentions, there is little information on what
happens in a genetic counselling session and how this process
affects patient outcomes.
Outcome studies in genetic counselling have largely relied on
women’s subjective assessment of the content and process of
counselling, with few including an objective measure of what
actually happened during the consultation. Furthermore, outcomes
are often restricted to measures of satisfaction and understanding
of risk. Such studies create a rather simplistic view of the goals of
genetic counselling (Emery et al, 1972; Kessler, 1981).
Furthermore, many of these studies did not evaluate the role of
patient’s sociodemographic factors (Evers Kiebooms and Van den
Berghe, 1979; Marteau and Richards, 1996). The samples
comprised women being counselled for a wide array of conditions,
including chromosomal, autosomal recessive and a small propor-
tion of autosomal dominant conditions, did not adequately control
for or measure counsellor variability and used ad hoc measures of
patient’s input and outcome variables (Michie, 1993).
The current study describes the process of genetic counselling
for women from familial breast cancer families as shown by the
analysis of audiotapes of counselling consultations. It examines the
effect of different consultant communication styles on a variety of
outcomes.
It was hypothesised that the more the consultant facilitated
communication and the more information was provided, the better
would be patient outcomes; (a) higher knowledge; (b) more
accurate risk perception; (c) higher total satisfaction, satisfaction
with the information given and satisfaction that expectations were
met; (d) more expectations being met; (e) lower generalised
anxiety and depression; and (f) lower anxiety about breast cancer.
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Participants
Women from high-risk breast cancer families who were attending
their first consultation before genetic testing, in any one of 10
familial cancer clinics in four Australian States, were included in
the study. Four clinical geneticists, one oncologist and two genetic
counsellors conducted consultations. Women were quota-sampled
according to whether or not they had previously had breast cancer.
Women were considered ineligible for participation if they were
unable to give informed consent, that is, if they were younger than
18 years or showed evidence of a severe mental illness. Individuals
with limited literacy in English were also excluded because data
collection was based on a self-administered questionnaire. None of
the women had had a predictive test for, or was an obligate carrier
of, a BRCA1 or BRCA2 mutation.
Of the 231 women who met the eligibility criteria, 27 women did
not attend their appointment and 11 declined participation. Of the
remaining 193 women, 158 women completed baseline (and
follow-up) questionnaires, for whom there was an audible
audiotape of their consultation.
A sample size of 158 women will detect a difference of 1.3 scores
on the Hospital Anxiety and Depression Scale anxiety subscale as a
result of consultants’ communication with 82% power at a
significance level of P¼0.05. This difference corresponds to an
effect size of 0.32 (i.e. a small to medium effect), according to
Cohen’s (1988) definition.
Procedure
This study is one component of a larger randomised controlled
trial of providing women with an audiotape of their genetic
counselling consultation (Lobb et al, 2002a), and the influence of
patient characteristics on consultants’ communication (Lobb et al,
2002b). Staff at each of the participating clinics invited women to
participate in the study (between November 1998 and May 2000)
when they telephoned to make their appointment. If verbal
agreement was obtained, women were mailed self-administered
questionnaires 2 weeks before and 4 weeks after their genetic
consultation. The consultations were audiotaped and copies of the
audiotape were retained for analysis. Ethics approval was obtained
from 10 different ethics committees prior to data collection.
Coding of transcripts of audiotapes
A detailed coding system and manual for the transcribed
audiotapes were devised. The transcripts were coded to capture
10 aspects of genetic counselling including (a) information giving
concerning: (i) breast cancer genetics, (ii) genetic testing, (iii)
family history and risk, (iv) prophylactic surgery, (v) breast cancer
prevention, (vi) screening and management; (b) Communication
style: including (vii) facilitating patient involvement, (viii) facil-
itating understanding, (ix) patient centredness and partnership
building and (x) supportive and counselling communications.
These categories were based on (a) the National Health & Medical
Research Council’s Guidelines on the Familial Aspects of Cancer: A
Guide to Clinical Practice (NH&MRC, 1999) and (b) an Australian
survey of clinical geneticists/genetic counsellors describing their
practice (Lobb et al, 2001) and (c) studies that identified women’s
expectations of the genetic counselling session (Julian-Reynier
et al, 1996, 1998; Hallowell et al, 1997; Michie et al, 1997; Veach
et al, 1999; Brain et al, 2000).
Under each of these categories, the content or types of
communication that characterised that issue were identified. The
presence or absence of each component was coded. Whether the
woman or the consultant initiated the content was noted and,
finally, the actual words used were recorded. An example of coding
for an information variable is shown in Table 1, and a
communication style variable is shown in Table 2. For example,
the category of Information on Screening and Management had 16
component topics that were summed to provide a total score.
Coding reliability
Three coders (including EL) were trained. Two coders recoded a
random 10% of their own consultation transcripts and 10% of the
other coder’s transcripts. The average interrater reliability over the
274 codes was 93% (range 67–100%) and the average intrarater
reliability was 92% (range 65–100%). The areas of highest
agreement were information-giving categories (e.g. risk (96–
100%); screening (89–99%); and there were lower levels of
agreement on some consultant communication styles: facilitating
communication (67–87%) and discussing psychosocial issues
(69–76%). Thus, interpretation of findings on these latter variables
must be viewed with some caution.
MEASURES
Predictors
Demographic characteristics Women were asked to provide
details on age, education, occupation, marital status, medical or
allied health training, and the number of biological children and
sex of each child.
Table 1 Example of Information-giving variables
Content of category
% of consultations in
which it occurred
Screening and management recommendations
Breast Cancer Screening
Mammography 89
Risks 19
Benefits 18
Direct recommendation 68
Screening other female family members 42
Ultrasound 34
Clinical breast examination 67
Breast self-examination 62
Tamoxifen 58
Risks 32
Benefits 27
Tamoxifen clinical trial 41
Ovarian cancer screening
Pelvic ultrasound 40
CA125 blood test 24
Risks 32
Benefits 27
Table 2 Example of communication styles
Supportive or counselling communication
Checking patient concerns 56%
Discussing feelings about coming to clinic 32%
Discussing feelings about own/family br.ca. 63%
Discussing feelings about having genetic test 36%
Discussing feelings of being at risk 44%
Discussing emotional concerns 57%
Discussing social concerns 22%
Discussing medical concerns (not genetics) 12%
Offering follow-up appointment 57%
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Breast cancer genetics knowledge Before and after the consulta-
tion, an eight-item true–false measure derived from one developed
by Lerman et al (1996) assessed knowledge about breast cancer
genetics.
Expectations Prior to the consultation, women indicated on a
five-point scale ranging from ‘not at all important’ to ‘very
important’ their response to seven possible reasons for attending a
genetic clinic and similarly rated nine possible information topics
that they might want covered at their first appointment. This scale
was developed for the purposes of this study and included items
suggested by expert opinion, the literature and structured
telephone interviews with at-risk women. The total scores of
expectations (possible range 0–7) and information sought (range
0–9) were calculated and compared to what women experienced
according to the coded transcribed consultation.
Perceived risk Before and after the consultation, women were
asked to estimate their risk of developing breast cancer over their
lifetime (or if affected, a second breast cancer) by choosing
between nine response options ranging from 1 in 100 (1%) to
inevitable (100%).
Participants’ numerical estimate of lifetime risk was converted
to a category, according to the figures given in the Australian
National Health & Medical Research Council Guidelines, for
example, a potentially high-risk category (25–80% lifetime risk of
breast cancer), a moderate-risk category (12–25%) and an
average-risk category (9–12%) (NH&MRC, 1999). These figures
were constructed acknowledging the limitations of risk analysis,
based on data with very wide confidence intervals. Standard
methods such as the Gail Model or Claus data are not commonly
used in Australia, particularly in defining high risk. According
to these NH&MRC guidelines, 60% of unaffected participants
in this study were categorised as potentially high risk, 31%
as moderate risk and 9% as at an average risk of developing breast
cancer.
Objective risk This was determined by the figure given by the
consultant in the consultation or the postconsultation summary
letter (all women received a figure in either of these communica-
tions). Participants’ responses were deemed accurate if their
risk estimate fitted within the risk category given by the
consultant. If a woman’s perception of risk fell on a cutoff
point of categories (12–25%), they were deemed accurate if
either of the categories in which they could be placed corre-
sponded with that given by the consultant. This method would
tend to increase the percentage of those considered accurate
compared to other methods. However, we felt that this was a more
valid approach as it reflects the actual figures (or words) given in
consultations. If women were inaccurate, it was determined
whether they had underestimated or overestimated their risk of
breast cancer.
Objective risk could be calculated only for unaffected women, as
in the majority of consultations (61%) and follow-up letters of
affected women, no risk figure or category was given of the
chances of getting a second breast cancer.
Breast cancer anxiety This was measured before and after the
consultation using the Impact of Events Scale, a 15-item reliable
and validated scale measuring intrusion and avoidance responses
in relation to a specific stressor (Horowitz et al, 1979; Thewes et al,
2001). In the current study, the particular stressor was concern
about being at risk of developing breast cancer for unaffected
women and concern about developing a second cancer for affected
women. Scores above 40 on either scale indicate a significant stress
response.
General anxiety and depression This was measured before and
after the consultation by the 14-item Hospital Anxiety and
Depression Scale, which is a valid and reliable measure. It consists
of two subscales of seven items assessing anxiety and depression
(Zigmond and Snaith, 1983). Questions have four response
options, giving scores ranging from 0 to 21 for each subscale. A
score of higher than 10 on either subscale is an indication of
clinical anxiety or depression.
Satisfaction with the genetic counselling session Satisfaction
was measured after the consultation using a modified version
of the 12-item short form of the 36-item ‘Satisfaction with
Genetic Counselling Scale’, developed by Shiloh et al (1990).
This shorter version of the scale is highly correlated with
the full scale (r¼0.90) and has good reliability (Cronbach
a¼0.78).
Statistical methods
Descriptive statistics were used to summarise most of the data,
including demographics and psychological status. Frequencies
were calculated for individual counsellor communication styles.
The total scores for the 10 predefined counselling categories were
calculated by summing the component items.
Univariate analyses exploring associations between (a)
demographic variables (education, occupation, medical/allied
health training, age and number of daughters), psychological
status, disease status (affected/unaffected) and consultation
styles; and (b) the outcomes listed above were undertaken
using parametric statistics (t-tests and Pearson’s correlations)
if the outcome score was normally distributed, and nonpara-
metric statistics (Mann–Whitney U and Spearman’s correlations)
if the outcome total score was non-normally distributed.
Some individual consultation communications were analysed
by w
2 analyses. Variables associated with the outcomes
at Po0.25 (Hosmer and Lemeshoe, 1989) were included in
multivariate analyses These analyses explored the effect of
consultant communications on outcomes, controlling for potential
confounders.
RESULTS
A total of 89 women were unaffected with breast cancer (56%) and
69 women were affected (44%). None were affected with ovarian
cancer. The majority had a family history of breast cancer only
(77%) and almost a quarter had a family history of breast and
ovarian cancer (23%). The demographic characteristics of the
women are shown in Table 3.
Overall impact of consultations on patient outcomes
At baseline, the mean number of correct answers to knowledge
items was 5.1. (s.d. 1.76) out of a possible 8. At the 4-week follow-
up, the median increase in knowledge as a result of genetic
counselling was 1.00 (s.d. 1.52, range  3 to 6).
The mean number of expectations met in the consultation was
4.06 (s.d. 1.70, range 0–7). Pearson’s correlations showed that
meeting women’s expectations was unrelated to their overall
satisfaction with the genetic counselling session (r¼0.001,
P¼0.99), their satisfaction with the information they received
(r¼0.069, P¼0.42) or satisfaction that their expectations were
met (r¼0.081, P¼0.34).
The mean change in anxiety score was  0.4308 (s.d. 2.97, range
 9 to 6) and that for depression  1.6923 (s.d. 2.56, range  9 to 7).
The mean change score in anxiety about breast cancer was  0.9256
(s.d. 4.52, range  15 to 12).
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At follow-up, 70% of unaffected women accurately estimated their
risk (compared to 50% at baseline). In total, 20% of unaffected
women underestimated their risk at follow-up (compared to 27%
at baseline) and 10% overestimated it (compared to 23% at
baseline).
Satisfaction with the genetic counselling session
In total, 95% of women felt that the consultant had explained their
situation clearly and 89% felt that their expectations were met. In
all, 82% thought the consultant showed enough dedication, 86%
felt that the consultant understood what was bothering them and
96% felt listened to. Finally, 84% were satisfied with the
information they received. The two areas where women, both
unaffected and affected, were less satisfied were in feeling
reassured (69 and 68%, respectively) and that the consultation
helped them cope better with their situation (68 and 57%,
respectively).
Multivariate analyses of the effect of consultants’ information-
giving and counselling communications on women’s outcomes
Information delivery: breast cancer genetics, genetic testing, family
history, breast cancer prevention, screening and management and
prophylactic surgery Women who had more aspects of genetic
testing discussed had a significant decrease in anxiety (median
HADS anxiety change score minus 1.000 vs 0.2333). (t¼ 2.22,
P¼0.03) compared to those who had not.
Women who had prophylactic mastectomy and oophorectomy
discussed reported significantly more expectations met (mean 4.76
and 4.92, respectively), than women who did not have these
discussed (mean 3.25 and 3.46, respectively) (OR¼7.34, 95%
CI¼1.96–27.57, P¼0.003) for mastectomy and (OR¼17.72, 95%
CI¼2.07–151.62, P¼0.009) for oophorectomy. There was also a
trend for discussion of these issues to be associated with a greater
reduction in anxiety about breast cancer, but these associations
did not reach significance (Po0.1). No other associations were
found between information-giving and patient outcomes.
Facilitating understanding, facilitating involvement, partnership
building, patient centredness and supportive and counselling
communications Women whose consultants facilitated under-
standing more had a significantly greater decrease in depression
(median HADS change in depression score  1.093 vs  1.988).
(t¼ 1.959, P¼0.052).
Women whose consultants used four or more supportive
communications were significantly more anxious about breast
cancer at 4 weeks follow-up (median IES Intrusion change score
0.1458 vs  1.844). (OR¼1.66,95% CI¼1.25–2.19, P¼0.000). We
examined whether the women who received more supportive and
counselling communications were more anxious at baseline than
those women who received fewer, but a significant association was
not found (z¼ 1.58, P¼0.11).
Receiving a written summary of the genetic counselling session -
Copies of the summary letter sent to women after their
consultation were obtained for all women participating in the
study. However, only 50% of the women had received a copy of
their letter by the follow-up assessment. Of these, almost all (92%)
reported that they had read it.
Multivariate analyses showed that women who had received a
letter summarising their consultation had lower anxiety (median
score  1.304 vs 0.544), OR¼0.38, 95% CI¼0.177–0.806,
P¼0.012, a trend towards less anxiety about breast cancer
(median score  0.058 vs  1.78), OR¼0.50, 95% CI¼0.221–
1.112, P¼0.089 and increased risk accuracy (79% were accurate vs
58%) OR¼2.61, 95% CI¼1.139–6.017, P¼0.023 compared to
those women who had not received a summary letter.
A summary of significant results from multiple logistic and
linear regression analyses of outcomes of consultants’ commu-
nications is shown in Table 4.
DISCUSSION
This study has provided a detailed analysis of the process of
genetic counselling in familial breast cancer within the Australian
context. It has been the first study that has audiotaped, transcribed
and coded in detail the process of genetic counselling in a large
group of women who are affected and unaffected with breast
cancer and who are members of potentially high-risk breast cancer
families.
The role of the clinical geneticist and genetic counsellor in
cancer genetic services is considerable. They routinely initiate
contact with the family, obtain a pedigree, obtain consent from
Table 3 Demographic characteristics of sample (n¼158)
Category Unaffected (n¼89) Affected (n¼69)
Age Mean 38.65 years (s.d. 9.0) (range 19–60) 51.36 (s.d. 11.5) (range 28–79)
Marital status Married 73.9% 79.7%
Not married 26.1% 20.3%
Educational level Below HSC (year 12) 36.0% 56.3%
Above HSC 64.0% 43.7%
Occupation Professionals 59.3% 53.6%
Nonprofessional 40.1% 46.4%
Allied health trained Yes 35.6% 29.0%
No 64.4% 71.0%
Children
Girls No girls 49.4% 24.6%
1 or more 50.6% 75.4%
Boys No boys 53.9% 39.1%
1 or more 46.1% 60.9%
Risk status High-risk 60%
Moderate 31%
Average 9%
Not all categories sum to 100 due to missing data.
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history, ascertain family beliefs about the inheritance pattern,
advise family members of their risks and options and arrange
clinical screening (Richards, 1993).
In recent reviews outlining the process of cancer genetic
counselling (Kelly, 1999; Peters et al, 1999; Stopfer, 2000), the
provision of emotional support and reassurance was identified as
an important role for genetic counsellors. One author argues that
genetic counselling must be psychodynamically oriented, recom-
mending that the counsellor be sufficiently versed in psychology or
psychiatry to recognise the emotions of the patient and the family
members and to help them deal effectively with these emotions
(Lynch and Lynch, 1996). This study explored the effect of
communications targeting both understanding and emotional
adjustment in genetic counselling consultations.
The high levels of breast cancer-related distress reported in
other studies (Kash et al, 1992; Lerman et al, 1997; Watson et al,
1999) were not found in this study. However, around 18% of
women were highly anxious and about 4% were significantly
depressed. A surprising finding of this study was that the women
who saw consultants who counselled and supported them were
more anxious about breast cancer at follow-up. These women did
not have elevated anxiety about breast cancer prior to their genetic
consultation, so it does not appear that consultants were
responding to existing high anxiety by providing more support,
nor that these women had high anxiety that was resistant to
change.
As long-term outcomes were not assessed in this study, the
duration of heightened anxiety and its effect is not known.
Increased anxiety is not necessarily inappropriate in the context of
genetic counselling, as a family history of breast cancer can raise
many emotional issues for women. For example, familial breast
cancer can cause premature death and involve a number of female
family members; hence loss and grief issues are frequently
prominent for the woman. Perhaps both women and counsellors
underestimate the impact of addressing these emotional concerns,
possibly previously unacknowledged. Some authors suggest that
women need to discuss their feelings of loss and anxiety about the
future first, to enable them to focus on the genetic issues (Carter
and Hailey, 1999; Stopfer, 2000). Therefore, we are not suggesting
that the current finding be used as a rationale to reduce the
counselling component of genetic counselling.
Australian providers of genetic counselling cited identifying the
woman’s individual needs and concerns as a major goal of genetic
counselling (Lobb et al, 2001). Previous authors have argued that
the success of the genetic counselling session is dependent upon
the counsellor accurately gauging the woman’s needs and
expectations and that the woman’s agenda be discussed at the
beginning of the counselling session (Hallowell et al, 1997).
The consultant elicited the woman’s agenda in 69% of
consultations but contrary to our hypothesis, women who were
asked their agenda did not have improved outcomes. Perhaps,
consultants are not exploring women’s agendas in sufficient detail,
nor following through on information at this point. In another
analysis of these data reported elsewhere, we found that
consultants were not responsive to women’s expectations or their
level of psychological distress prior to the consultation (Lobb et al,
2002b).
This study found that women who had prophylactic mastectomy
and oophorectomy discussed had significantly more expectations
met. Hopwood (1997) has suggested that women attending genetic
counselling clinics are likely to be information seekers who cope
by monitoring their environment and taking action to reduce risk
(Hopwood, 1997).
While the Australian NH&MRC National Best Practice Guide-
lines for Familial Cancer Clinics (1997) recommend that con-
sultants discuss prophylactic mastectomy and oophorectomy with
all women from high-risk families, perhaps some practitioners feel
concerned about women’s response to its discussion. Our findings
suggest that women wish to discuss the option of prophylactic
surgery and that discussing this area of management does not
cause psychological distress.
While 77% of affected women indicated that they wanted to
know their chances of developing a second cancer (in the contra
lateral breast), this was not discussed in 61% of consultations,
perhaps because consultants felt concerned that the woman was
still adjusting to her current breast cancer diagnosis. Similarly, the
majority of affected women (98%) wanted to know their family’s
risk of developing breast cancer and this was given in under half of
the consultations (44%).
The provision of other information and also, surprisingly,
facilitation of active involvement were not associated with patient
outcomes. Perhaps, women in the current study became over-
loaded with information. The findings that providing a written
summary after the consultation (a technique to simplify and
summarise information) lessened anxiety and, importantly,
increased their accuracy of risk perception after the session,
supports previous research that found written summaries of
genetic consultations to be beneficial (Hallowell and Murton,
1998). Importantly, the facilitation of understanding was asso-
ciated with reduced depression at follow-up, suggesting that
women struggle with the large amount of information provided
and can feel worse if they are not helped to understand it.
Future research and recommendations
Further research is needed to develop and evaluate interventions
that identify and address anxiety levels in women attending for
Table 4 Summary of significant results from multiple logistic and linear regression analyses of outcomes of consultants’ communication
Outcome OR 95% CI P-value
Consultant discussed prophylactic mastectomy
Expectations met (mean 4.76 vs 3.25) 7.34 1.96–27.57 0.003
Consultant discussed prophylactic oophorectomy
Expectations met (mean 4.92 vs 3.46) 17.72 2.07–151.62 0.009
Consultant use of supportive or counselling communications
Change in breast cancer anxiety (median 0.1458 vs  1.844) 1.66 1.25–2.10 0.001
Summary letter of consultation (received and read)
Risk perception Accuracy (79% vs 58%) 2.61 1.14–6.02 0.023
Change in general anxiety (median  1.304 vs 0.544) 0.38 0.177–0.81 0.012
Consultant discussed genetic testing b 95%CI tP
Change in general anxiety (median change score  1.000 vs 0.2333)  0.204  0.542– 0.031  2.22 0.028
Consultant facilitated understanding
Change in depression (median change score  1.093 vs  1.988)  0.171  0.479–0.002  1.959 0.052
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increase in anxiety about breast cancer identified with increased
supportive and counselling communications may be due to
emotional issues being raised without adequate resolution. It
may be helpful for consultants not only to assess psychological
stress before the consultation but to also keep checking during the
consultation as to how the woman is coping. Training programmes
to assist clinicians identify and respond more consistently to the
needs and concerns of women attending genetic counselling in the
familial breast cancer setting may be helpful. Some consultants
may consider such psychological strategies beyond their role and
prefer a multidisciplinary approach where referral for appropriate
counselling can be initiated.
Important findings of this study are that the provision of a
summary letter after the consultation increased women’s accuracy
of risk perception and reduced anxiety, and that communications
that facilitated understanding led to a greater reduction in
depression. Few studies to date have been able to identify ways
to improve women’s risk perception after counselling. It is
recommended that the practice of providing written summaries
continue, that women are encouraged to review the letter and that
other mechanisms to help women understand genetic information
are explored. Finally, research into individual counsellor differ-
ences would be useful and investigation of more subtle commu-
nication behaviours than those measured here.
Limitations of the study
It should be acknowledged that while verbal communication could
be accurately coded from the audiotapes, it was not possible to
capture nonverbal communication. It is possible that if nonverbal
cues were included in the analysis quite a different result would
have been obtained. Additionally, as has been identified in
previous studies in the familial cancer setting, women in this
study tended to be of higher education and professional status
than the general population. The percentage of women with
tertiary qualifications was 57% compared with 37% in the
Australian population (Australian Bureau of Statistics, 1997). As
there were few refusals to participate in the study (n¼11), our
study does seem to reflect accurately the population who attend for
genetic counselling. Thus, while these findings may not be
generalisable to less educated women, they do appear generalisable
to the target population.
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